The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice

Cancer cachexia is a debilitating syndrome characterized by skeletal muscle wasting, weakness and fatigue. Several pathogenetic mechanisms can contribute to these muscle derangements. Mitochondrial alterations, altered metabolism and increased oxidative stress are known to promote muscle weakness an...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Frontiers in cell and developmental biology Ročník 10; s. 861622
Hlavní autoři:	Pin, Fabrizio, Huot, Joshua R., Bonetto, Andrea
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media SA 22.03.2022 Frontiers Media S.A
Témata:	AKT protein Antioxidants Atrophy Body weight loss Cachexia Cancer Cell and Developmental Biology Chemotherapy Dehydrogenases Drinking water Enzymatic activity Gene expression Gene regulation Genotype & phenotype Glycolysis Hexokinase Homeostasis Kinases Laboratory animals Low density lipoprotein Low density lipoprotein receptors Medical prognosis Metabolism Metastases Mitochondria MitoQ muscle Musculoskeletal system Oxidative metabolism Oxidative stress Penicillin Phosphorylation Pyruvic acid Skeletal muscle Succinate dehydrogenase TOR protein Tumors Indiana United States > US cancer metabolism MitoQ mitochondria cachexia muscle
ISSN:	2296-634X, 2296-634X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!